Clinical Trials on Community-Acquired Pneumoniae

Total 12432 results

GlaxoSmithKline

Terminated

A Study to Evaluate Single and Repeat Doses of IV GSK2251052 in Healthy Male Japanese and Caucasian Subjects and Repeat Doses of Supratherapeutic Doses of IV GSK2251052 in Healthy Volunteers

Community-acquired Infection

United States
GlaxoSmithKline

Completed

An Open-label, Randomized, Single Period, Parallel-Cohort Study To Evaluate Serum and Pulmonary Pharmacokinetics Following Single and Multiple Dose Administration of Intravenous GSK2251052 in Healthy Adult Subjects

Community-acquired Infection

United States
GlaxoSmithKline

Terminated

A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase Study (Relative Bio)

Community-acquired Infection

Australia
GlaxoSmithKline

Completed

GSK2251052 Mass Balance in Healthy Adult Subjects

Community-acquired Infection

Netherlands
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Tigecycline In-Vitro Surveillance Study In Taiwan

Community Acquired Infections

China
University of Colorado, Denver
Pfizer

Completed

Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala

Community-acquired Pneumonia | Streptococcus Pneumoniae Infection

Guatemala
University Children's Hospital, Zurich
University Children's Hospital Basel; Ostschweizer Kinderspital

Unknown

Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone Therapy (myKIDS-STEP)

Community-acquired Pneumonia

Switzerland
Universidad de la Sabana

Recruiting

Pneumococcal Nasopharyngeal Colonization as Predictor of Community-Acquired Pneumonia (CAP) in Adults With Chronic Diseases. (CAP)

Community-acquired Pneumonia | Streptococcus Pneumoniae Infection | Streptococcus Pneumoniae Pneumonia | Streptococcus Pneumoniae Infection Invasive

Colombia
Christoph Berger

Not yet recruiting

A Trial of Placebo Versus Macrolide for Mycoplasma Pneumoniae Childhood Pneumonia: MYTHIC Study (MYTHIC)

Community Acquired Pneumonia in Children | Mycoplasma Pneumoniae | Mycoplasma Pneumoniae Pneumonia

Switzerland
University Medical Centre Ljubljana
University of Ljubljana, Faculty of Medicine

Unknown

The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia (SCAHAVAP)

Community Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired Pneumonia

Slovenia
Indiana University

Withdrawn

Hospital Acquired and Community Acquired MRSA in GI Lab

Hospital Acquired MRSA | Community Acquired MRSA

United States
Chinese University of Hong Kong

Recruiting

Evaluation of Streptococcus Pneumoniae Serotypes Prevalence Using a Urinary Kit

Community-acquired Pneumonia

Hong Kong
Basilea Pharmaceutica

Completed

Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia

Community-acquired Pneumonia (CAP) | Hospital-acquired Pneumonia (HAP)

Bulgaria, Hungary, Georgia, Romania
Laval University

Unknown

An Evaluation of a Dynamic Web-Based Visualization of Community Immunity

Understanding of Community Immunity as a Concept
Future University in Egypt

Recruiting

Study of the Efficacy and Safety of Antioxidants Astaxanthin as an Adjuvant Therapy for Community Acquired Pneumonia Patients.

Community-acquired Pneumonia

Egypt
Nordsjaellands Hospital

Recruiting

Physical Training During Hospital Admission With Community-Acquired Pneumonia

Community-acquired Pneumonia

Denmark
Thomas Benfield

Recruiting

Shortened Antibiotic Treatment of 5 Days in Community-Acquired Pneumonia (CAP5)

Community-acquired Pneumonia

Denmark
Hannover Medical School

Recruiting

pedCAPNETZ - Community Acquired Pneumonia (CAP) in Childhood and Adolescence (pedCAPNETZ)

Community-acquired Pneumonia

Germany
University of Roma La Sapienza
Azienda Policlinico Umberto I

Recruiting

Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL) (COLOSSEUM)

Community-acquired Pneumonia

Italy
Julia Bielicki
University Hospital, Basel, Switzerland; Swiss National Fund for Scientific...

Completed

KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP (KIDS-STEP)

Community-acquired Pneumonia

Switzerland, Germany
Assistance Publique - Hôpitaux de Paris

Completed

Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia (MULTI-CAP)

Community-acquired Pneumonia

France
Asian Foundation for Tropical Medicine Inc.
Pfizer; Southern Philippines Medical Center; Philippine Children's Medical Center...

Active, not recruiting

PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study (IMPACT)

Community-acquired Pneumonia

Philippines
TaiGen Biotechnology Co., Ltd.

Completed

Oral Nemonoxacin in Treating Elderly Patients With CAP

Community-acquired Pneumonia

Taiwan
Northwestern University

Withdrawn

Use of a Rapid Diagnostic Test for Antibiotic De-escalation in Severe Community Acquired Pneumonia (BioFire)

Community-acquired Pneumonia
Nabriva Therapeutics AG

Completed

Study to Compare Lefamulin to Moxifloxacin (With or Without Linezolid) for the Treatment of Adults With Pneumonia (LEAP)

Community Acquired Pneumonia

United States, Argentina, Bosnia and Herzegovina, Brazil, Bulgaria, Georgia, Hungary, Latvia, Netherlands, Peru, Philippines, Poland, Romania, Russian Federation, Serbia, South Africa, Thailand, Ukraine
China Academy of Chinese Medical Sciences
The First Affiliated Hospital of Tianjin University of Traditional Chinese...

Unknown

Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumonia

Community-acquired Pneumonia
Gertrud Baunbaek Egelund

Unknown

Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia (BIO-CAP)

Community Acquired Pneumonia

Denmark
Hospital General de Niños Pedro de Elizalde

Withdrawn

Corticosteroids in Community-acquired Pneumonia

Community-acquired Pneumonia

Argentina
Federal University of Minas Gerais

Withdrawn

Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired Pneumonia (CAP-Marker)

Community-acquired Pneumonia

Brazil
Muğla Sıtkı Koçman University

Completed

Potential Role for Echocardiography in Adult Patients With Community-Acquired Pneumonia

Community-acquired Pneumonia

Turkey
Indonesia University

Unknown

Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients

Community-Acquired Pneumonia

Indonesia
IASO Pharma Inc.

Terminated

Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia

Community Acquired Pneumonia

United States
Pfizer

Completed

A Global Active Surveillance for Community Acquired Pneumonia

Community Acquired Pneumonia

Poland
Capital Medical University

Unknown

The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing

Community Acquired Pneumonia

China
Cairo University

Completed

Corticosteroids in Community Acquired Pneumonea

Community Acquired Pneumonia
Beijing Hospital

Unknown

Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors

Community-Acquired Pneumonia

China
Hellenic Institute for the Study of Sepsis

Active, not recruiting

Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia (INSPIRE)

Hospital-acquired Pneumonia | Community-acquired Pneumonia

Greece
Liverpool University Hospitals NHS Foundation Trust
Liverpool School of Tropical Medicine

Completed

HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections (HOMEFIRST)

Community Acquired Pneumonia | Lower Respiratory Tract Infection | Hospital Acquired Pneumonia

United Kingdom
National University of Malaysia

Completed

Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients

Critical Illness | Hospital-acquired Pneumonia | Community-acquired Pneumonia | Severe Pneumonia

Malaysia
Capital Medical University

Recruiting

Diagnosis and Treatment Strategy Optimization of Severe Pneumonia Based on Multi-omics Data Integration

Severe Community-acquired Pneumonia

China
Pfizer

Completed

PCV13 Effectiveness Study Against Hospitalised VT Pneumococcal CAP in Adults 60 Years and Older

Community Acquired Pneumonia (CAP)

Spain
Fundacio d'Investigacio en Atencio Primaria Jordi...

Terminated

Efficacy of High Doses Penicillin V Versus High Doses Amoxicillin in the Treatment of Non-severe Pneumonia. (PENIPNEUMO)

Community-acquired Pneumonia (CAP)

Spain
Melinta Therapeutics, Inc.

Completed

Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia

Community-Acquired Pneumonia (CAP)

Canada, United States, Russian Federation
Pfizer

Completed

The Study Of Azithromycin Switch Therapy For Treatment Of Community Acquired Pneumonia (CAP)

Community Acquired Pneumonia (CAP)

Japan
Assiut University

Not yet recruiting

Community-Acquired Pneumonia Diagnosis Through Integrating Novel Microbiological Techniques.

Community-acquired Pneumonia
Nantes University Hospital

Not yet recruiting

Amoxicillin Alone Versus Amoxicillin/Clavulanate for Community-acquired Pneumonia in Patients Aged 65 Years or Older, and Hospitalized in a Non-intensive Care Unit Ward (CAPTAIN)

Community-acquired Pneumonia
Jeffrey Pernica

Recruiting

Optimizing Care for Children Hospitalized With Community-acquired Pneumonia: Short-course Therapy (PRESTO-2)

Community-acquired Pneumonia

Canada
Assiut University

Not yet recruiting

Role of Multiplex PCR in CAP

Community-acquired Pneumonia
Qianfoshan Hospital

Recruiting

Characteristics of Hospitalized Patients With Community-acquired Pneumonia

Community-acquired Pneumonia

China
University of Manitoba
Canadian Institutes of Health Research (CIHR); Ozmosis Research Inc.; Canadian... and other collaborators

Recruiting

AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP)

Community-acquired Pneumonia

Canada, United States, Brazil

Clinical Trials on Community-Acquired Pneumoniae

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations